Stone Pharmaceutical Group Amoxilin Dispersion Tablets are supplemented by a consistent evaluation

Amoxicillin belongs to penicillin-type broad-spectrum β-endamide antibiotics, which have strong antibacterial and bactericidal effects on most disease-caused Gloranian-positive bacteria and Terratin-negative bacteria, and are widely used in clinical treatment for upper respiratory tract infections, genitourinary tract infections, skin soft tissue infections, lower respiratory tract infections and the eradication of Helicobacter pylhobacteria in association with other drugs, and do not require dose adjustment in patients with mild and moderate kidney disease. According to
meters of intranet data, in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal Amoxilin sales of more than 1.7 billion yuan, an increase of 15.18 percent year-on-year.
China's public medical institutions terminal Amoxilin sales source: Minet China's public medical institutions terminal competition pattern At present, Amoxilin domestic market has capsules, tablets, granules, dispersion tablets, injections and other dosage forms, of which amoxicillin oral regular release agent type for the second batch of collection varieties, Amoxicillin granules for the third batch of collection varieties.
Shi Pharmaceutical Group through / as if through the consistent evaluation of varieties source: Minet MED2.0 China Pharmaceutical Review Database Amosillin dispersal tablets for the first domestic evaluation, before the company's Amosillin tablets, Amosillin capsules have also passed the consistent evaluation.
, Stone Pharmaceutical Group has 39 varieties (57 product rules) through / as if through the consistency evaluation, of which 15 varieties for the first evaluation.
source: MiNet Database, NMPA